how do you stop taking glp 1 What Happens If GLP-1 Injections? to Prevent Weight Regain GLP-1 Medications Infographic | Medidex
Description
Adults with type 2 diabetes and overweight or obesity who use a GLP-1 receptor agonist have similar risk for kidney cancer as those using an SGLT2 inhibitor, according to findings from a target trial emulation
These choices are often based on personal experience rather than clinical evidence, making provider guidance important
Denis Raccah, Email: [email protected]
Make maintenance a primary goal
Exploratory analyses We tested our moderation hypotheses by mean-centering each proposed moderator and testing the interaction between the moderator and study condition in a multiple linear regression model
